| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $639.8M | — | +33.5% |
| Cost of Revenue | $184.2M | — | +59.3% |
| Gross Profit | $455.6M | — | +25.3% |
| R&D Expense | $151.0M | — | +31.2% |
| SG&A Expense | $95.0M | — | +8.4% |
| Operating Income | -$62.0M | — | -16.4% |
| Pre-tax Income | -$21.4M | — | +41.8% |
| Income Tax | $1.5M | — | -10.0% |
| Net Income | -$22.9M | — | +40.4% |
| EPS (Basic) | -$0.07 | — | +36.4% |
| EPS (Diluted) | -$0.07 | — | +36.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $932.2M | -1.2% | +355.9% |
| Accounts Receivable | $379.6M | -0.8% | +32.6% |
| Current Assets | $4.72B | +1.5% | +79.7% |
| Total Assets | $6.16B | +2.1% | +65.6% |
| Current Liabilities | $2.41B | +2.6% | +193.6% |
| Total Liabilities | $4.64B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $158.3M | — | +8.6% |
| Capital Expenditures | $65.2M | — | -24.1% |
| Investing Cash Flow | -$158.8M | — | -71.8% |
| Financing Cash Flow | -$9.5M | — | -368.8% |
| Free Cash Flow | $93.1M | — | +55.4% |
| +102.0% |
| Stockholders' Equity | $1.53B | +4.6% | +7.1% |